| Impact of high dose of baricitinib in severe COVID-19 pneumonia: a prospective cohort study in Bangladesh MJ Hasan, R Rabbani, AM Anam, SMR Huq, MMI Polash, SST Nessa, ... BMC Infectious Diseases 21 (1), 427, 2021 | 49 | 2021 |
| Additional baricitinib loading dose improves clinical outcome in COVID-19 MJ Hasan, R Rabbani, AM Anam, SMR Huq Open Medicine 16 (1), 041-046, 2020 | 23 | 2020 |
| Bloodstream infection with pandrug-resistant Alcaligenes faecalis treated with double-dose of tigecycline MJ Hasan, LN Nizhu, R Rabbani IDCases 18, e00600, 2019 | 23 | 2019 |
| Impact of comorbidities on clinical outcome of patients with COVID-19: evidence from a single-center in Bangladesh MJ Hasan, AM Anam, SMR Huq, R Rabbani Health Scope 10 (1), 2021 | 13 | 2021 |
| High-voltage electrocution-induced pulmonary injury and cerebellar hemorrhage with fractures in atlas LN Nizhu, MJ Hasan, R Rabbani Trauma case reports 25, 100267, 2020 | 11 | 2020 |
| Secukinumab in severe COVID-19 pneumonia: Does it have a clinical impact? MJ Hasan, R Rabbani, AM Anam, SMR Huq Journal of Infection 83 (1), e11-e13, 2021 | 10 | 2021 |
| The Susceptibility of MDR-to Polymyxin B Plus its Nebulised Form Versus Polymyxin B Alone in Critically Ill South Asian Patients MJ Hasan, R Rabbani, AM Anam, A Santini, SMR Huq The Journal of Critical Care Medicine 7 (1), 28-36, 2021 | 7 | 2021 |
| Intravenous N-acetylcysteine in severe cutaneous drug reaction treatment: A case series MJ Hasan, R Rabbani SAGE Open Medical Case Reports 8, 2050313X20934708, 2020 | 7 | 2020 |
| Donepezil: an unusual therapy for acute diphenhydramine overdose J Ahmad, MJ Hasan, AM Anam, DK Barua BMJ Case Reports CP 12 (3), e226836, 2019 | 7 | 2019 |
| N-acetylcysteine in severe COVID-19: The possible mechanism MJ Hasan International Journal of Infection 7 (4), 2020 | 6 | 2020 |
| The pandemic COVID-19 and the auspicious role of frontier pharmacists against this global threat MJ Hasan, J Nead Pharmacology & Pharmacy 11 (9), 209-225, 2020 | 5 | 2020 |
| Therapeutic specification of the last resort polymyxins: an intelligent approach MJ Hasan, R Rabbani, SC Bachar International Journal of Infection 6 (4), 2019 | 5 | 2019 |
| Bloodstream infection with pan drug-resistant Alcaligenes faecalis treated with double-dose of tigecycline. IDCases 18: e00600 MJ Hasan, LN Nizhu, R Rabbani | 5 | 2019 |
| The resistance growing trend of common gram-negative bacteria to the potential antibiotics over three consecutive years: a single center experience in Bangladesh MJ Hasan, MS Hosen, SC Bachar Pharm Pharmacol Int J 7 (3), 114-9, 2019 | 5 | 2019 |
| Critical care pharmacist using free drug-interaction checker mobile apps can ensure medication safety in critically ill patients MJ Hasan, R Rabbani, SC Bachar Jundishapur Journal of Health Sciences 12 (2), 2020 | 4 | 2020 |
| Polymyxins nebulization over intravenous injection: pharmacokinetics and pharmacodynamics-based therapeutic evaluation MJ Hasan Journal of Pharmaceutical Research International 25 (4), 1-10, 2019 | 4 | 2019 |
| Tocilizumab in COVID-19 treatment: a cost-burden in low-and middle-income countries MJ Hasan International Journal of Health and Life Sciences 6 (2), 2020 | 3 | 2020 |
| The use of high dose eltrombopag in the management of sepsis-associated thrombocytopenia in critically ill patients MJ Hasan, R Rabbani, SMR Huq The Journal of Critical Care Medicine 5 (4), 123-129, 2019 | 3 | 2019 |
| The need for adequate research data on carbapenem use and resistance in Bangladesh MJ Hasan, R Rabbani The Lancet Infectious Diseases 19 (8), 811, 2019 | 3 | 2019 |
| Severe hypoalbuminemia increases the risk of thrombocytopenia in critically ill adult patients receiving teicoplanin MJ Hasan, R Rabbani, SC Bachar Dhaka University Journal of Pharmaceutical Sciences 18 (2), 153-157, 2019 | 3 | 2019 |
Sitesh Chandra BacharUniversity of DhakaVerified email at du.ac.bd
